Based on molecular evidence, BC can be categorized into three groups: hormone receptor [estrogen receptor (ER) or progesterone receptor (PR)]-positive, human epidermal receptor 2 (HER2) or ERBB2 receptor-positive, and triple-negative BC (TNBC; ER−, PR−, HER2−). This evidence concerns the gene ERBB2 and breast cancer.